CO2021003676A2 - Procesos para la preparación de 4-{8-amino-3-[(2s)-1-(but-2-inoil)pirrolidin-2-il]imidazo[1,5-a]-pirazin-1-il}-n-(piridin-2-il)benzamida - Google Patents

Procesos para la preparación de 4-{8-amino-3-[(2s)-1-(but-2-inoil)pirrolidin-2-il]imidazo[1,5-a]-pirazin-1-il}-n-(piridin-2-il)benzamida

Info

Publication number
CO2021003676A2
CO2021003676A2 CONC2021/0003676A CO2021003676A CO2021003676A2 CO 2021003676 A2 CO2021003676 A2 CO 2021003676A2 CO 2021003676 A CO2021003676 A CO 2021003676A CO 2021003676 A2 CO2021003676 A2 CO 2021003676A2
Authority
CO
Colombia
Prior art keywords
processes
ynoyl
pyrazin
imidazo
pyrrolidin
Prior art date
Application number
CONC2021/0003676A
Other languages
English (en)
Spanish (es)
Inventor
Paul Allen Bethel
Lai Chun Chan
Katie Grace Cooper
Robert John Cox
Michael David Golden
Shaun Alan Hughes
Lucinda Victoria Jackson
Kirsty Jane Millard
Andrew John Phillips
Alexander James Telford
Jerry Evarts
Michael Joseph Lawler
Remy E J N Litjens
Eijk Peter Johannes Servaas Savio Van
Mathilda Maria Henrica Verstappen
Frank L M Vos
Eric Jurriën Zijp
Qiu Junying
Angang Wang
Rustam Ferdinand Garrey
David Allen Short
Original Assignee
Acerta Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acerta Pharma Bv filed Critical Acerta Pharma Bv
Publication of CO2021003676A2 publication Critical patent/CO2021003676A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CONC2021/0003676A 2018-08-29 2021-03-23 Procesos para la preparación de 4-{8-amino-3-[(2s)-1-(but-2-inoil)pirrolidin-2-il]imidazo[1,5-a]-pirazin-1-il}-n-(piridin-2-il)benzamida CO2021003676A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862724228P 2018-08-29 2018-08-29
PCT/EP2019/072991 WO2020043787A1 (en) 2018-08-29 2019-08-28 Processes for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide

Publications (1)

Publication Number Publication Date
CO2021003676A2 true CO2021003676A2 (es) 2021-04-08

Family

ID=67928802

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0003676A CO2021003676A2 (es) 2018-08-29 2021-03-23 Procesos para la preparación de 4-{8-amino-3-[(2s)-1-(but-2-inoil)pirrolidin-2-il]imidazo[1,5-a]-pirazin-1-il}-n-(piridin-2-il)benzamida

Country Status (16)

Country Link
US (3) US12024520B2 (cg-RX-API-DMAC10.html)
EP (1) EP3844149A1 (cg-RX-API-DMAC10.html)
JP (3) JP7439095B2 (cg-RX-API-DMAC10.html)
KR (2) KR20250119664A (cg-RX-API-DMAC10.html)
CN (2) CN112638878B (cg-RX-API-DMAC10.html)
AU (4) AU2019332882B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021003480A2 (cg-RX-API-DMAC10.html)
CA (1) CA3109734A1 (cg-RX-API-DMAC10.html)
CO (1) CO2021003676A2 (cg-RX-API-DMAC10.html)
EA (1) EA202190557A1 (cg-RX-API-DMAC10.html)
IL (3) IL281025B2 (cg-RX-API-DMAC10.html)
MA (1) MA53485A (cg-RX-API-DMAC10.html)
MX (2) MX2021002246A (cg-RX-API-DMAC10.html)
MY (1) MY206899A (cg-RX-API-DMAC10.html)
WO (1) WO2020043787A1 (cg-RX-API-DMAC10.html)
ZA (2) ZA202306381B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250119664A (ko) * 2018-08-29 2025-08-07 아세르타 파마. 비.브이. 4-{8-아미노-3-[(2S)-1-(부트-2-이노일)-피롤리딘-2-일]이미다조[1,5-a]-피라진-1-일}N-(피리딘-2-일)-벤즈아미드의제조 공정
EP3947386A1 (en) * 2019-03-27 2022-02-09 Assia Chemical Industries Ltd Solid state forms of acalabrutinib
DK4054582T3 (da) 2019-11-04 2025-12-01 Astrazeneca Ab Terapeutiske kombinationer af acalabrutinib og capivasertib til behandling af b-celle-maligniteter
CR20230018A (es) 2020-06-19 2023-04-11 Acerta Pharma Bv Formas farmacéuticas de maleato de acalabrutinib

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2372694T3 (es) 2003-10-15 2012-01-25 OSI Pharmaceuticals, LLC Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina.
EP2139487B1 (en) 2007-03-28 2015-11-11 Pharmacyclics LLC Inhibitors of bruton's tyrosine kinase
US8362249B2 (en) 2009-04-27 2013-01-29 Boehringer Ingelheim International Gmbh CXCR3 receptor antagonists
US8765754B2 (en) 2009-04-29 2014-07-01 Locus Pharmaceuticals, Inc. Pyrrolotriazine compounds
US8658794B2 (en) 2010-02-08 2014-02-25 Merck Sharp & Dohme B.V. 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof
CN103889987B (zh) * 2011-07-19 2016-09-14 默沙东有限责任公司 作为btk抑制剂的选择的咪唑并吡嗪类
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
WO2014113942A1 (en) 2013-01-23 2014-07-31 Merck Sharp & Dohme Corp. Btk inhibitors
MX362181B (es) 2013-02-19 2019-01-08 Ono Pharmaceutical Co Compuesto inhibidor de cinasa del receptor de tropomiosina (trk).
US9512084B2 (en) 2013-11-29 2016-12-06 Novartis Ag Amino pyrimidine derivatives
WO2016128912A1 (en) 2015-02-12 2016-08-18 Acerta Pharma B.V. Therapeutic combinations of a btk inhibitor, a pi3k inhibitor, a jak-2 inhibitor, a pd-1 inhibitor, and/or a pd-l1 inhibitor
IL293821A (en) 2015-07-02 2022-08-01 Acerta Pharma Bv Solid forms and formulations of (S)-4-(8-amino-3-(1-(but-2-aminoyl)pyrrolidine-2-yl)imidazo[5,1-yl]pyrazin-1-yl)-en- (pyridine-2-yl)benzamide
WO2017077507A1 (en) * 2015-11-06 2017-05-11 Acerta Pharma B.V. Imidazopyrazine inhibitors of bruton's tyrosine kinase
CN107056786B (zh) 2016-10-14 2019-05-07 苏州明锐医药科技有限公司 阿卡替尼的制备方法
ES2856248T3 (es) 2016-12-21 2021-09-27 Acerta Pharma Bv Inhibidores de imidazopirazina de la tirosina quinasa de Bruton
WO2018115965A1 (en) * 2016-12-23 2018-06-28 Acerta Pharma Bv Solid forms of imidazopyrazine compounds
CN106588937B (zh) 2017-01-16 2018-09-21 东莞市真兴贝特医药技术有限公司 咪唑并吡嗪类化合物及其制备方法和应用
US10899770B2 (en) 2017-02-20 2021-01-26 Hangzhou Solipharma Co., Ltd. Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof
US10800787B2 (en) 2017-04-20 2020-10-13 Apotex Inc. Process for the preparation of acalabrutinib
CN107522701B (zh) 2017-09-01 2019-11-08 苏州富士莱医药股份有限公司 一种治疗慢性淋巴细胞白血病的BTK抑制剂Acalabrutinib的合成方法
US11161851B2 (en) 2017-11-06 2021-11-02 Suzhou Pengxu Pharmatech Co. Ltd. Processes to produce acalabrutinib
CN108250186B (zh) * 2018-02-07 2020-01-14 杭州科巢生物科技有限公司 Acalabrutinib及其中间体的合成方法
WO2019239374A1 (en) 2018-06-13 2019-12-19 Acerta Pharma B.V. Imidazopyrazine inhibitors of interleukin-2-inducible t-cell kinase
KR20250119664A (ko) * 2018-08-29 2025-08-07 아세르타 파마. 비.브이. 4-{8-아미노-3-[(2S)-1-(부트-2-이노일)-피롤리딘-2-일]이미다조[1,5-a]-피라진-1-일}N-(피리딘-2-일)-벤즈아미드의제조 공정
WO2020085504A1 (ja) 2018-10-26 2020-04-30 大鵬薬品工業株式会社 光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法

Also Published As

Publication number Publication date
CA3109734A1 (en) 2020-03-05
MX2023011692A (es) 2023-10-19
US20240317766A1 (en) 2024-09-26
JP2026021364A (ja) 2026-02-10
KR20210053304A (ko) 2021-05-11
AU2023204660A1 (en) 2023-08-03
IL322382A (en) 2025-09-01
AU2023204660B2 (en) 2024-01-25
WO2020043787A1 (en) 2020-03-05
IL281025B1 (en) 2024-08-01
JP2024037935A (ja) 2024-03-19
US12448387B2 (en) 2025-10-21
AU2022200828B2 (en) 2023-05-25
KR102842131B1 (ko) 2025-08-04
CN112638878A (zh) 2021-04-09
JP2021535220A (ja) 2021-12-16
CN112638878B (zh) 2025-07-22
KR20250119664A (ko) 2025-08-07
IL281025A (en) 2021-04-29
JP7829541B2 (ja) 2026-03-13
AU2024202290A1 (en) 2024-05-02
US12024520B2 (en) 2024-07-02
MX2021002246A (es) 2021-05-27
IL312413A (en) 2024-06-01
CN120904205A (zh) 2025-11-07
US20260109701A1 (en) 2026-04-23
MA53485A (fr) 2021-12-08
IL312413B1 (en) 2025-09-01
ZA202306381B (en) 2024-11-27
ZA202409391B (en) 2025-04-30
EA202190557A1 (ru) 2021-07-13
AU2022200828A1 (en) 2022-03-03
EP3844149A1 (en) 2021-07-07
JP7439095B2 (ja) 2024-02-27
BR112021003480A2 (pt) 2021-05-18
AU2019332882A1 (en) 2021-04-22
AU2019332882B2 (en) 2022-01-27
IL312413B2 (en) 2026-01-01
MY206899A (en) 2025-01-13
US20220127270A1 (en) 2022-04-28
IL281025B2 (en) 2024-12-01

Similar Documents

Publication Publication Date Title
ZA202409391B (en) Processes for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide
CL2015002386A1 (es) Nuevos octahidro-pirrolo[3,4-c)-pirrol y -piridina-fenilo.
SV2018005740A (es) Metodos para tratar la depresion con antagonistas del receptor de orexina-2
MX2021013812A (es) Procesos para la preparacion de (3s,4r)-3-etil-4-(3h-imidazo[1,2-a ]pirrolo[2,3-e]-pirazin-8-il)-n-(2,2,2-trifluoroetil) pirrolidin-1-carboxamida y formas en estado solido de la misma.
CO2021014022A2 (es) Compuestos de 4h-pirrolo[3,2-c]piridin-4-ona
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
PH12020550132A1 (en) Novel enantiomers of a series of antiviral compounds
WO2014101986A8 (en) Dry granulation process for producing tablet compositions of metformin and compositions thereof
UY29341A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación
MY200355A (en) Process for the manufacturing of methane sulfonic acid
PH12016500250B1 (en) Novel triazolo [4,5-d] pyrimidine derivatives
BR112015020904A2 (pt) microrganismos e métodos para produção de butadieno e compostos relacionados por assimilação de formiato
PH12020550537A1 (en) Bicyclic sulfones and sulfoxides and methods of use thereof
PT3596080T (pt) Derivados de pirazolo [1,5-a]pirimidina substituídos com alicíclico farmacologicamente ativos
MX2020008110A (es) Sal de compuesto de pirazolo[1,5-a]pirimidina y cristales de la misma.
IN2014KN02722A (cg-RX-API-DMAC10.html)
CL2018002344A1 (es) Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina
MX2018014684A (es) Derivados de [1,2,3]triazolo[4,5-d]pirimidina con afinidad para el receptor de canabinoide de tipo 2.
MX2018010939A (es) Instalacion de produccion para componentes de tubo.
MX2019002077A (es) Formas cristalinas y formas de sal de compuestos de 7h-pirrolo[2,3-d]pirimidina y metodo de preparacion de las mismas.
AR098958A1 (es) Formas cristalinas de un compuesto antiviral antecedentes
DOP2006000015A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación
WO2020053795A3 (en) Process for the preparation of acalabrutinib and its intermediates
CL2010000980A1 (es) Metodo de ensamble para fabricacion de muebles mediante el ensamble de 4 o mas piezas planas que trabajan mecanicamenteentre si para mantener estable su estructura, a traves de ranuras de union;una mecedora; taburete: estante;mesa de cama para pc portatil taburete bar;y esquinero .
PH12022551548A1 (en) Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof